0,775  0,014  Caspase 9 stimulant
0,737  0,005  UGT1A6 substrate
0,729  0,005  UGT1A9 substrate
0,721  0,008  Prostate cancer treatment
0,735  0,025  Antiinflammatory
0,714  0,013  TNF expression inhibitor
0,659  0,005  UGT1A4 substrate
0,650  0,006  Antipruritic, allergic
0,658  0,016  CYP2C9 substrate
0,652  0,011  Sensitization
0,659  0,019  Teratogen
0,657  0,022  CYP3A4 substrate
0,649  0,014  Respiratory analeptic
0,641  0,009  NOS3 expression inhibitor
0,626  0,011  CTGF expression inhibitor
0,616  0,010  Cardiovascular analeptic
0,631  0,026  Antineoplastic (lung cancer)
0,622  0,021  Embryotoxic
0,609  0,011  Cytostatic
0,612  0,017  Aldehyde oxidase inhibitor
0,620  0,029  Transcription factor NF kappa B inhibitor
0,600  0,011  AR expression inhibitor
0,600  0,011  NOS2 expression inhibitor
0,606  0,018  Cholesterol antagonist
0,584  0,004  UGT2B4 substrate
0,577  0,005  Sulfotransferase substrate
0,573  0,004  Contraceptive
0,571  0,003  UGT2B15 substrate
0,582  0,016  CYP2C19 substrate
0,602  0,049  Apoptosis agonist
0,546  0,003  Lipocortins synthesis antagonist
0,554  0,017  Analeptic
0,555  0,020  Immunosuppressant
0,525  0,008  Antihypoxic
0,525  0,011  UDP-glucuronosyltransferase substrate
0,518  0,004  Abortion inducer
0,507  0,004  UGT2B7 substrate
0,498  0,007  Anesthetic
0,534  0,047  Antineoplastic (breast cancer)
0,485  0,004  Contraceptive male
0,483  0,003  UGT2B9 substrate
0,504  0,025  Antihypercholesterolemic
0,478  0,004  Antipruritic, non-allergic
0,483  0,011  UGT1A1 substrate
0,460  0,005  Interleukin 6 antagonist
0,481  0,031  Bone diseases treatment
0,467  0,018  Nitric oxide antagonist
0,452  0,009  Prostatic (benign) hyperplasia treatment
0,445  0,008  Sodium/bile acid cotransporter inhibitor
0,445  0,012  Anesthetic general
0,453  0,023  Chemopreventive
0,455  0,027  Antiosteoporotic
0,431  0,010  Hair growth stimulant
0,430  0,010  Melanin inhibitor
0,427  0,009  Prostate disorders treatment
0,432  0,014  Antimutagenic
0,424  0,009  Interferon gamma antagonist
0,436  0,024  Proliferative diseases treatment
0,463  0,052  Antibacterial
0,415  0,006  Endometrios treatment
0,420  0,018  Calcium channel activator
0,411  0,010  Antiacne
0,423  0,033  Cytotoxic
0,390  0,004  Contraceptive female
0,421  0,038  Hepatic disorders treatment
0,411  0,036  ICAM1 expression inhibitor
0,380  0,013  UGT1A3 substrate
0,356  0,003  UGT2B10 substrate
0,365  0,012  Pneumotoxic
0,415  0,063  GST A substrate
0,355  0,004  SULT1A1 substrate
0,388  0,041  Cardioprotectant
0,382  0,035  Hypoxia-inducible factor 1 alpha inhibitor
0,388  0,042  CYP1A2 substrate
0,351  0,009  Neurotrophic factor enhancer
0,357  0,021  GST M1-1 substrate
0,381  0,048  CYP2D6 substrate
0,339  0,007  Antifungal enhancer
0,367  0,036  Carcinogenic
0,336  0,004  Postmenopausal disorders treatment
0,381  0,051  Antifungal
0,358  0,030  Antineoplastic (endocrine cancer)
0,335  0,014  Genotoxic
0,326  0,007  UGT2B1 substrate
0,336  0,022  Antiviral (Influenza)
0,366  0,053  Antineoplastic (ovarian cancer)
0,326  0,014  Antiviral (Influenza A)
0,332  0,022  Hepatoprotectant
0,346  0,037  Mutagenic
0,353  0,044  Interleukin 2 agonist
0,346  0,045  Chemoprotective
0,305  0,005  Estrogen agonist
0,326  0,027  RNA-directed DNA polymerase inhibitor
0,346  0,047  Antioxidant
0,313  0,020  Glyceraldehyde-3-phosphate dehydrogenase inhibitor
0,290  0,002  Arachidonic acid antagonist
0,322  0,037  DNA synthesis inhibitor
0,307  0,023  VCAM1 expression inhibitor
0,314  0,039  Antiparasitic
0,283  0,008  Androgen antagonist
0,286  0,011  Psychosexual dysfunction treatment
0,283  0,011  Antineoplastic antibiotic
0,273  0,003  Androgen agonist
0,287  0,019  Protein kinase stimulant
0,274  0,005  Aromatase inhibitor
0,334  0,070  Antineoplastic (colorectal cancer)
0,285  0,023  Carcinogenic, group 3
0,268  0,008  Estrogen antagonist
0,327  0,067  Antineoplastic (colon cancer)
0,260  0,002  RNA-directed RNA polymerase stimulant
0,287  0,030  Peptidyltransferase inhibitor
0,258  0,002  UGT2B11 substrate
0,257  0,006  Antirickettsial
0,262  0,017  Toxic, respiratory center
0,273  0,035  P-glycoprotein inhibitor
0,244  0,007  Growth stimulant
0,254  0,017  Cholesterol synthesis inhibitor
0,245  0,009  Antineoplastic, alkylator
0,260  0,024  NOS3 expression enhancer
0,275  0,040  Antihypotensive
0,234  0,002  Anabolic
0,254  0,023  Antipruritic
0,289  0,058  Tumour necrosis factor alpha release inhibitor
0,300  0,070  5 Hydroxytryptamine release stimulant
0,288  0,061  Antineoplastic (cervical cancer)
0,287  0,061  Antineoplastic (glioma)
0,296  0,071  Antineoplastic (melanoma)
0,259  0,035  Eye irritation, high
0,236  0,012  Microtubule formation inhibitor
0,228  0,005  Adenylate cyclase stimulant
0,241  0,020  Adenylate cyclase inhibitor
0,228  0,008  Estrogen receptor beta antagonist
0,298  0,087  Apoptosis antagonist
0,242  0,032  Antineoplastic (squamous cell carcinoma)
0,260  0,052  Antihypertriglyceridemic
0,306  0,099  Antileukemic
0,274  0,068  Flavin-containing monooxygenase substrate
0,249  0,045  Antihelmintic
0,268  0,066  Interleukin agonist
0,259  0,061  Antineoplastic (sarcoma)
0,203  0,005  Cushing's syndrome treatment
0,274  0,079  Radioprotector
0,208  0,015  Choleretic
0,257  0,068  Antineoplastic (liver cancer)
0,269  0,082  Antineoplastic (pancreatic cancer)
0,271  0,084  FMO3 substrate
0,258  0,073  5 Hydroxytryptamine uptake stimulant
0,198  0,014  Antineoplastic alkaloid
0,210  0,030  ATPase inhibitor
0,182  0,003  Hypogonadism treatment
0,215  0,037  VEGF expression inhibitor
0,301  0,124  CYP2C19 inhibitor
0,183  0,009  Estrogen receptor alpha antagonist
0,206  0,032  Alpha-N-acetylglucosaminidase inhibitor
0,183  0,008  SULT1E1 substrate
0,201  0,028  DNA polymerase I inhibitor
0,180  0,007  Ca2+-transporting ATPase inhibitor
0,177  0,005  Estrogen receptor beta agonist
0,189  0,019  Alcohol dehydrogenase substrate
0,196  0,027  Glutathione S-transferase substrate
0,168  0,002  Postcoital contraceptive
0,239  0,075  Angiogenesis stimulant
0,193  0,029  Antihyperlipoproteinemic
0,186  0,024  Expectorant
0,179  0,017  Antispirochetal
0,166  0,005  Aldosterone antagonist
0,187  0,026  Farnesoid X receptor antagonist
0,181  0,021  Menstruation disorders treatment
0,244  0,086  Gastrin inhibitor
0,177  0,020  Mucolytic
0,262  0,105  Antineoplastic (osteosarcoma)
0,217  0,064  Nitric-oxide synthase stimulant
0,204  0,051  Tumour necrosis factor antagonist
0,189  0,035  SULT1A3 substrate
0,160  0,008  Premenstrual syndrome treatment
0,158  0,006  Glycine receptor antagonist
0,155  0,004  Glucocorticoid antagonist
0,173  0,024  Pregnane X receptor agonist
0,183  0,036  Neurotrophic factor
0,262  0,116  FMO1 substrate
0,200  0,054  LDLR expression enhancer
0,175  0,030  Antihemorrhagic
0,162  0,017  Actinic keratosis treatment
0,145  0,003  SULT2A1 substrate
0,251  0,111  Caspase 3 stimulant
0,191  0,051  Phospholipase C inhibitor
0,214  0,076  Antiparkinsonian, rigidity relieving
0,217  0,082  Antineoplastic (lymphoma)
0,148  0,015  Keratolytic
0,139  0,007  Estradiol 17 beta-dehydrogenase inhibitor
0,184  0,054  Phobic disorders treatment
0,222  0,093  Antipyretic
0,145  0,017  Paget's disease treatment
0,180  0,052  Antineoplastic (carcinoma)
0,155  0,027  UDP-glucose 4-epimerase inhibitor
0,261  0,133  Ulceration
0,135  0,008  Anticholelithogenic
0,164  0,037  Cyclooxygenase 3 inhibitor
0,231  0,105  Radiosensitizer
0,207  0,081  Antineoplastic (glioblastoma multiforme)
0,142  0,018  Antiviral (Trachoma)
0,158  0,034  Coagulant
0,178  0,055  Diuretic
0,133  0,010  Na+ K+ transporting ATPase inhibitor
0,130  0,009  Narcotic antagonist
0,126  0,006  Estrogen receptor alpha agonist
0,156  0,036  Carcinogenic, group 2B
0,122  0,004  Estradiol 17 beta-dehydrogenase 3 inhibitor
0,146  0,028  Antiinfertility, female
0,176  0,059  Antiviral (Herpes)
0,130  0,013  Alcohol oxidase inhibitor
0,144  0,028  Chronic obstructive bronchitis treatment
0,123  0,007  Progesterone antagonist
0,149  0,034  Interleukin 8 antagonist
0,157  0,043  Alkylator
0,199  0,087  Antialcoholic
0,225  0,116  Antiepileptic
0,131  0,024  Antibiotic
0,163  0,058  Amylase inhibitor
0,150  0,045  Antitussive
0,164  0,059  Lipid peroxidase inhibitor
0,107  0,004  Lipocortins synthesis agonist
0,107  0,007  Mineralocorticoid receptor antagonist
0,163  0,064  Hexokinase inhibitor
0,107  0,010  Antimycoplasmal
0,098  0,004  Progesterone agonist
0,139  0,046  Topoisomerase I inhibitor
0,129  0,035  Creatine kinase inhibitor
0,103  0,010  5-Alpha-reductase inhibitor
0,097  0,004  Pregnane X receptor antagonist
0,109  0,016  Glycine receptor agonist
0,101  0,010  3(or 17)beta-hydroxysteroid dehydrogenase inhibitor
0,129  0,042  AMP-activated protein kinase stimulant
0,125  0,039  Toll-Like receptor 4 antagonist
0,222  0,136  Mood disorders treatment
0,143  0,059  Skin whitener
0,144  0,061  Antieczematic
0,127  0,045  HDL-cholesterol increasing
0,087  0,005  Adenylate cyclase 1 inhibitor
0,134  0,054  Monophenol monooxygenase inhibitor
0,111  0,030  Bile acid receptor antagonist
0,103  0,023  SULT1A2 substrate
0,188  0,108  Antiprotozoal (Leishmania)
0,197  0,118  DNA damaging
0,199  0,121  Immunostimulant
0,128  0,052  Antiviral (Influenza B)
0,106  0,030  Opioid kappa receptor antagonist
0,157  0,082  Growth hormone agonist
0,079  0,005  Steroid 17-alpha-hydroxylase/17,20 lyase inhibitor
0,111  0,038  Potassium channel activator
0,100  0,027  Antiviral (Dengue virus)
0,094  0,021  Antitreponemal
0,083  0,011  Potassium channel Kv1.3 blocker
0,154  0,083  Sigma receptor agonist
0,085  0,014  Andropause treatment
0,109  0,040  Triose-phosphate isomerase inhibitor
0,086  0,017  Protein 50S ribosomal subunit inhibitor
0,147  0,078  Movement disorders treatment
0,156  0,089  Aldehyde oxidase substrate
0,105  0,039  Ornithine decarboxylase inhibitor
0,171  0,105  Cardiodepressant
0,100  0,034  Antiprotozoal activity enhancer
0,096  0,030  Estrogen-related receptor beta agonist
0,123  0,058  Skin irritative effect
0,081  0,019  Hypercalcemia treatment
0,124  0,062  Antineoplastic antimetabolite
0,145  0,084  Aldose reductase substrate
0,093  0,035  Phosphofructokinase-1 inhibitor
0,064  0,006  Glucose-6-phosphate dehydrogenase inhibitor
0,118  0,060  Photosensitizer
0,121  0,065  Autism spectrum disorders treatment
0,075  0,019  Heme oxygenase stimulant
0,109  0,053  Antihypermotility
0,068  0,016  Anesthetic inhalation
0,089  0,037  Glutamate dehydrogenase inhibitor
0,056  0,004  Glucocorticoid agonist
0,117  0,065  Protein-tyrosine phosphatase 1B inhibitor
0,097  0,048  NADH dehydrogenase inhibitor
0,075  0,027  Argininosuccinate synthase inhibitor
0,176  0,130  Age-related macular degeneration treatment
0,178  0,132  Vascular (periferal) disease treatment
0,210  0,166  Antithrombotic
0,052  0,008  11-Beta-hydroxysteroid dehydrogenase 2 inhibitor
0,047  0,004  Hedgehog signaling activator
0,114  0,071  Anesthetic local
0,083  0,041  Antidote, organophosphates
0,064  0,022  Alpha-mannosidase inhibitor
0,091  0,050  Transcription factor NF kappa B stimulant
0,104  0,063  Antiviral (Poxvirus)
0,049  0,009  Vanilloid 3 antagonist
0,191  0,153  Tyrosine 3 hydroxylase inhibitor
0,041  0,004  Corticosteroid-like
0,097  0,059  Posttraumatic stress disorder treatment
0,064  0,027  Ryanodine receptor antagonist
0,044  0,008  5-Alpha-reductase 2 inhibitor
0,121  0,085  Vanilloid 1 agonist
0,090  0,054  Tocolytic
0,056  0,020  Microtubule stabilization
0,165  0,129  Cyclic AMP phosphodiesterase inhibitor
0,201  0,166  Antineoplastic (brain cancer)
0,048  0,014  Antihyperaldosteronism
0,137  0,104  Uterine stimulant
0,124  0,092  Acaricide
0,091  0,059  Glutamate release inhibitor
0,033  0,001  Transcortin receptor antagonist
0,149  0,117  Antiviral (Hepatitis)
0,034  0,003  Telomerase stimulant
0,125  0,094  CC chemokine 6 receptor antagonist
0,156  0,125  Insulin sensitizer
0,054  0,024  Glucose-6-phosphate isomerase inhibitor
0,188  0,157  Antidepressant
0,197  0,167  Antiallergic
0,042  0,013  Tubulin agonist
0,161  0,132  Free radical scavenger
0,041  0,012  ATP citrate lysase inhibitor
0,134  0,105  Antihelmintic (Nematodes)
0,083  0,055  T cell inhibitor
0,166  0,138  Antineoplastic (renal cancer)
0,097  0,072  Adenylate kinase inhibitor
0,136  0,112  Antiviral (Hepatitis C)
0,063  0,040  Carbamoyl phosphate synthetase inhibitor
0,133  0,110  CF transmembrane conductance regulator agonist
0,042  0,019  Antibiotic Aminoglycoside-like
0,086  0,065  GST P1-1 substrate
0,032  0,010  Estrone sulfatase inhibitor
0,145  0,123  Succinate dehydrogenase inhibitor
0,025  0,005  Histone-lysine N-methyltransferase EZH2 inhibitor
0,126  0,106  Protein-tyrosine phosphatase inhibitor
0,028  0,008  Vitamin D receptor antagonist
0,048  0,028  Mannosidase inhibitor
0,124  0,105  Antidiabetic (type 1)
0,076  0,057  MAP kinase kinase 7 inhibitor
0,198  0,178  Vasodilator, peripheral
0,105  0,087  Antiseptic
0,024  0,005  Antibiotic Anthracycline-like
0,027  0,009  5-Alpha-reductase 1 inhibitor
0,020  0,003  3 Beta-hydroxy-delta 5-steroid dehydrogenase inhibitor
0,024  0,008  Progesterone receptor B antagonist
0,110  0,094  Antifungal (Pneumocystis)
0,026  0,011  GRP78 expression inhibitor
0,044  0,029  Opioid kappa receptor agonist
0,097  0,083  GST T1-1 substrate
0,149  0,136  Antiulcerative
0,041  0,027  Cholesterol absorption inhibitor
0,038  0,024  2,3-Oxidosqualene-lanosterol cyclase inhibitor
0,081  0,068  Opioid antagonist
0,091  0,079  Nav1.1 sodium channel blocker
0,104  0,091  Aldehyde dehydrogenase inhibitor
0,017  0,006  Antibiotic Tetracycline-like
0,055  0,044  Acetyl-CoA transferase 2 inhibitor
0,111  0,103  Antiprotozoal (Trichomonas)
0,119  0,111  Antiprotozoal (Coccidial)
0,059  0,051  Antiviral (Parainfluenza)
0,086  0,078  Lanosterol 14 alpha demethylase inhibitor
0,017  0,010  Vitamin D receptor agonist
0,012  0,005  Progesterone receptor A antagonist
0,036  0,029  Farnesoid X receptor agonist
0,096  0,090  Topoisomerase II inhibitor
0,022  0,019  Protein 30S ribosomal subunit inhibitor
0,042  0,038  11-Beta-hydroxysteroid dehydrogenase 1 inhibitor
0,019  0,019  Estradiol 17 beta-dehydrogenase 1 inhibitor
0,241  0,241  5 Hydroxytryptamine release inhibitor

